MENLO PARK, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the "Company"), a clinical-stage biotechnology company with its lead indication in Phase...
MENLO PARK, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the "Company"), a clinical-stage biotechnology company with its lead indication in Phase...
MENLO PARK, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:Â ATNF)Â (180 Life Sciences or the "Company"), a clinical-stage biotechnology company with its lead indication in...
MENLO PARK, Calif., Dec. 03, 2020 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:Â ATNF)Â ("180 Life Sciences" or "the Company"), a clinical-stage biotechnology company with its lead indication...
MENLO PARK, Calif., Nov. 24, 2020 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:Â ATNF)Â (180 Life Sciences or the "Company"), a clinical-stage biotechnology company with its lead indication in...
MENLO PARK, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:Â ATNFÂ or the "Company"), a clinical-stage biotechnology company with its lead indication in Phase 2b/3, focused...
MENLO PARK, Calif., Nov. 17, 2020 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:Â ATNFÂ or the "Company"), a clinical-stage biotechnology company with its lead indication in Phase 2b/3, focused...
Company Now Publicly Traded on Nasdaq Under the ticker ATNF